Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other Accumulated Expenses: 2015

Historic Other Accumulated Expenses for Cartesian Therapeutics (RNAC) over the last 1 years, with Dec 2015 value amounting to $223,000.

  • Cartesian Therapeutics' Other Accumulated Expenses was N/A to $831,000 in Q2 2016 from the same period last year, while for Jun 2016 it was $831,000, marking a year-over-year change of. This contributed to the annual value of $223,000 for FY2015, which is N/A change from last year.
  • Per Cartesian Therapeutics' latest filing, its Other Accumulated Expenses stood at $223,000 for FY2015.
  • In the past 5 years, Cartesian Therapeutics' Other Accumulated Expenses ranged from a high of $223,000 in FY2015 and a low of $223,000 during FY2015.
  • Its 1-year average for Other Accumulated Expenses is $223,000, with a median of $223,000 in 2015.